Breast Cancer Invasive Clinical Trials

21 recruiting

Breast Cancer Invasive Trials at a Glance

21 actively recruiting trials for breast cancer invasive are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Shanghai, Sacramento, and Groningen. Lead sponsors running breast cancer invasive studies include Columbia University, Emory University, and Baylor Breast Care Center.

Browse breast cancer invasive trials by phase

Treatments under study

About Breast Cancer Invasive Clinical Trials

Looking for clinical trials for Breast Cancer Invasive? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Breast Cancer Invasive trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Breast Cancer Invasive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)

Breast CancerBreast Cancer FemaleBreast Neoplasms+5 more
iSono Health, Inc.800 enrolled1 locationNCT07505797
Recruiting
Phase 2

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Breast CancerBreast CarcinomaBreast Neoplasm+34 more
University of California, Davis86 enrolled1 locationNCT06268665
Recruiting
Not Applicable

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Prostate CancerBreast Cancer Invasive
Columbia University194 enrolled2 locationsNCT05351424
Recruiting
Phase 2

Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer

Breast CancerBreast Cancer Stage IIBreast Cancer Invasive+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's40 enrolled2 locationsNCT07188246
Recruiting
Phase 2

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

Breast Cancer Invasive
University of Illinois at Chicago40 enrolled1 locationNCT04891068
Recruiting
Not Applicable

Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB)

Breast Cancer SurgeryBreast Cancer InvasiveLumpectomy+1 more
University of Fribourg100 enrolled1 locationNCT06958991
Recruiting
Phase 3

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer

Breast Cancer Invasive
RenJi Hospital488 enrolled1 locationNCT05910398
Recruiting
Not Applicable

A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery

Breast Cancer Invasive
Sun Yat-sen University860 enrolled1 locationNCT06686459
Recruiting

NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.

Breast Cancer Invasive
Henan Cancer Hospital709 enrolled1 locationNCT06781281
Recruiting

Intra-operative Detection of Positive Margins in Breast Surgery

Breast Cancer Invasive
University of Nottingham120 enrolled1 locationNCT06977698
Recruiting

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Breast Cancer Stage IIBreast Cancer InvasiveBreast Cancer Stage III+1 more
Emory University10 enrolled1 locationNCT05877859
Recruiting

Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)

Breast Cancer Invasive
University of Bonn100 enrolled1 locationNCT06633276
Recruiting
Phase 2

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Breast CancerBreast Cancer FemaleBreast Neoplasm+3 more
Baylor Breast Care Center185 enrolled2 locationsNCT05020860
Recruiting
Phase 2

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

Breast Cancer InvasiveMetastatic CancerOligoprogressive
The Netherlands Cancer Institute118 enrolled7 locationsNCT05301881
Recruiting
Not Applicable

Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer

Breast Cancer Invasive
European Institute of Oncology92 enrolled1 locationNCT06790264
Recruiting

GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer

Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine50 enrolled1 locationNCT06725940
Recruiting
Not Applicable

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Breast Cancer Invasive
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1,380 enrolled2 locationsNCT06716073
Recruiting

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)

Breast CancerBreast Cancer InvasiveBreast Carcinoma in Situ+1 more
Uppsala University1,200 enrolled3 locationsNCT06401304
Recruiting
Not Applicable

Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study

Breast CancerBreast Cancer Invasive
University Medical Center Groningen70 enrolled2 locationsNCT05939310
Recruiting
Not Applicable

Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)

Breast Cancer Invasive
Seoul National University Hospital533 enrolled1 locationNCT05505357